Insigneo Advisory Services’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Insigneo Advisory Services's AQST Position: Q3 2026 in Review
Insigneo Advisory Services reduced its Aquestive Therapeutics (AQST) stake by 23% in Q3 2026, selling an estimated $19.8K and leaving 14,654 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #819.
Insigneo Advisory Services first reported a position in AQST in Q1 2026 and has held it in 3 quarters since. The position peaked at $79.5K in Q2 2026. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Insigneo Advisory Services held 14,654 shares of Aquestive Therapeutics worth $67.8K as of Q3 2026.
- Insigneo Advisory Services sold 4,464 Aquestive Therapeutics shares in Q3 2026, an estimated $19.8K.
- Aquestive Therapeutics made up ﹤0.01% of Insigneo Advisory Services's portfolio in Q3 2026, its #819 holding.
- Insigneo Advisory Services first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Insigneo Advisory Services's Aquestive Therapeutics position peaked at $79.5K in Q2 2026.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Insigneo Advisory Services's 13F filing for Q3 2026, filed 13 Nov 2026.